Home » Topics » BioWorld Science

BioWorld Science
RSS

3M Pharmaceuticals patents new vaccine adjuvants

July 16, 2019

MedImmune describes KEAP1/NRF2 interaction inhibitors

July 16, 2019

Alkermes plans to expand planned ALKS-3831 schizophrenia NDA to include bipolar I disorder

July 16, 2019

IDO1 inhibitors presented by Shanghai De Novo Pharmatech

July 16, 2019

Janssen Pharmaceutica identifies menin/MLL interaction inhibitors

July 16, 2019

NIAID grant supports development of Kineta's LHF-535 for hemorrhagic arenaviruses

July 16, 2019

Chengdu Huajian Future Technology patents IDO1 inhibitors

July 16, 2019

Synlogic reports topline data from phase I/IIa study of SYNB-1618 in patients with PKU

July 16, 2019

Arbutus reports preliminary phase Ia/Ib data on oral HBV capsid inhibitor AB-506

July 16, 2019

Sosei and Genentech enter GPCR-focused research collaboration and license agreement

July 16, 2019

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...